Table of Contents
Bone-Strengthening Drugs in Cancer: Bisphosphonates and Denosumab Explained
By Dr. Gajendra Kumar Himanshu
Bone-strengthening drugs are medicines used in some people with cancer to protect the bones, reduce the risk of fractures, and help manage problems caused when cancer spreads to the bones. The two main types are bisphosphonates, such as zoledronic acid and pamidronate, and denosumab. These medicines slow down the breakdown of bone and can reduce some bone-related complications.
When cancer spreads to the bones, the bones can become weak and painful. Some cancers, including breast cancer, prostate cancer, lung cancer, and multiple myeloma, are more likely to affect the bones. Bone-strengthening medicines are usually used along with the main cancer treatment, not as a replacement for it.
In this blog, we will explain how these medicines work, when they may be recommended, the difference between bisphosphonates and denosumab, possible side effects, and important precautions.
What Are Bone-Strengthening Drugs?
Bone-strengthening drugs are also called bone-modifying agents or antiresorptive medicines. They work by slowing down the activity of cells called osteoclasts. These cells normally break down old bone as part of the body’s natural bone-renewal process.
When cancer affects the bones, this process can become too active. The bones may then lose strength and become more likely to cause pain or break. Bisphosphonates and denosumab help slow this excessive bone breakdown.
For a simple explanation of what happens when cancer spreads to the bones, you can read our blog on bone metastasis symptoms.
When Are These Medicines Used in Cancer?
Doctors may recommend bone-strengthening treatment when cancer has spread to the bones or when there is a significant risk of bone-related problems. These problems may include fractures, bone pain, and other complications.
Denosumab is approved for preventing bone problems caused by multiple myeloma or solid tumours that have spread to bone. Bisphosphonates such as zoledronic acid and pamidronate are also used in patients with cancer-related bone disease.
These medicines may be used in cancers such as:
- Breast cancer that has spread to the bones
- Prostate cancer with bone involvement
- Some lung and other solid cancers with bone metastases
- Multiple myeloma
The decision depends on the type of cancer, bone involvement, kidney function, calcium levels, and overall health.
You can also learn more about multiple myeloma treatment and the medicines used for it, as bone health is an important part of care for many people with multiple myeloma.
How Do Bisphosphonates Work?
Bisphosphonates attach to bone and slow down the cells that break down bone. Common medicines used in cancer care include zoledronic acid and pamidronate. They are generally given through a vein as an intravenous infusion.
By slowing bone breakdown, these medicines may reduce bone pain and lower the risk of some skeletal complications. They are usually part of a wider treatment plan that may also include cancer medicines, pain treatment, radiation therapy, or surgery when needed.
The treatment schedule is different for each patient. Your oncologist will decide how often the medicine should be given based on your cancer and medical condition.
How Does Denosumab Work?
Denosumab is a different type of bone-strengthening medicine. It is a monoclonal antibody that blocks a protein called RANKL. This reduces the activity of osteoclasts and slows bone breakdown.
Unlike most cancer-related bisphosphonate treatments, denosumab is given as an injection under the skin rather than through a vein. It can be used to prevent bone problems in people with multiple myeloma or solid cancers that have spread to the bones.
The choice between denosumab and a bisphosphonate depends on the patient’s cancer, kidney function, calcium levels, previous treatment, and other health factors.
Bisphosphonates vs Denosumab
The table below compares the two main types of bone-strengthening medicines used in cancer care.
Feature | Bisphosphonates | Denosumab |
|---|---|---|
Common examples | Zoledronic acid, pamidronate | Denosumab |
How they work | Slow bone breakdown by affecting osteoclasts | Blocks RANKL and reduces osteoclast activity |
How given | Usually through a vein | Injection under the skin |
Cancer use | Bone metastases and some blood cancers | Bone metastases and multiple myeloma |
Kidney considerations | Kidney function is important when planning treatment | Does not require the same type of kidney dose adjustment |
Calcium levels | Need monitoring | Low calcium can occur and needs monitoring |
Jaw problems | Possible | Possible |
Choice of drug | Depends on individual condition | Depends on individual condition |
Both medicines can help reduce bone-related complications, but neither is suitable for every patient. Your cancer team will choose the option that best fits your health and treatment plan.
What Are the Benefits?
The main purpose of these medicines is to protect bones and reduce complications rather than directly cure the cancer.
Depending on the situation, they may help:
- Reduce cancer-related bone pain
- Lower the risk of some fractures
- Reduce other skeletal complications
- Help maintain bone strength
- Support quality of life when cancer has affected the bones
The National Cancer Institute notes that bisphosphonates and denosumab can be used as part of a wider approach to managing cancer-related bone pain and complications. They should generally be combined with appropriate cancer treatment and other pain-management methods when needed.
If bone pain is affecting daily life, you can also read our blog on cancer pain management for information about different ways pain can be managed.
What Side Effects Can Occur?
Like all medicines, bone-strengthening drugs can cause side effects. The risk depends on the medicine, dose, treatment duration, and the person’s overall health.
Bisphosphonates can sometimes cause fever, flu-like symptoms, muscle or joint pain, kidney problems, and changes in mineral levels. Kidney function is usually checked before treatment and during treatment when appropriate.
Denosumab can cause low calcium levels, which may lead to muscle cramps, tingling, or other symptoms when severe. Doctors may check calcium and other mineral levels during treatment.
Both types of medicines can rarely cause osteonecrosis of the jaw, a condition in which part of the jawbone becomes damaged and does not heal normally.
Why Dental Care Is Important
Dental health is particularly important before and during treatment with these medicines because of the possible risk of jaw problems.
Tell your oncologist about any dental problems before starting treatment. Your doctor may recommend a dental check-up, especially if you need tooth removal or other invasive dental work.
During treatment, maintain good oral hygiene and tell your healthcare team if you develop jaw pain, swelling, loose teeth, or a wound in the mouth that does not heal.
Do not stop or delay cancer treatment or bone-strengthening medicine on your own. Dental and cancer specialists can coordinate care when a dental procedure is needed.
What Should Patients Tell Their Doctor?
Before receiving a bone-strengthening medicine, tell your doctor if you have:
- Kidney disease
- Low calcium or vitamin D levels
- Dental or jaw problems
- Recent or planned dental surgery
- Other medicines or supplements that you take
Your doctor may check blood tests, kidney function, calcium levels, and other factors before deciding which medicine is appropriate.
For patients with blood cancers such as multiple myeloma, bone problems may be part of the disease itself. You can read more about common multiple myeloma symptoms and why bone-related symptoms should be evaluated.
Are These Medicines a Replacement for Cancer Treatment?
No. Bone-strengthening medicines are supportive treatments. They help manage or prevent bone complications but generally do not replace the main treatment for the cancer.
For example, a person with breast cancer that has spread to the bones may need systemic cancer treatment along with a bone-modifying medicine. A person with prostate cancer may need hormone therapy or other cancer treatment alongside treatment for bone health.
The exact combination depends on the cancer type, stage, bone involvement, and overall health.
Regular Monitoring During Treatment
Your doctor may regularly check blood tests and ask about symptoms during treatment. Monitoring helps identify problems such as changes in calcium levels or kidney function.
Tell your cancer team if you develop new or worsening bone pain, muscle cramps, tingling, weakness, jaw pain, or dental problems.
If cancer has spread to the bones, symptoms such as severe or sudden bone pain, weakness, numbness, or difficulty walking should receive prompt medical attention because they may sometimes indicate a serious bone or spinal complication.
Consult Today
Bone-strengthening medicines can be an important part of cancer care when cancer affects the bones. Bisphosphonates and denosumab work in different ways, but both aim to slow bone breakdown and reduce the risk of bone-related complications. The right medicine depends on the patient’s cancer, kidney function, calcium levels, dental health, and overall condition.
At Oncare Cancer Hospital, cancer specialists can assess your cancer diagnosis, bone involvement, test reports, and overall health before recommending an appropriate treatment plan. Bone-strengthening medicines may be combined with cancer treatment, pain management, radiation therapy, or other supportive care when needed.
Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always discuss decisions about bone-strengthening medicines, dental procedures, or any cancer treatment with a certified cancer healthcare provider.
Frequently Asked Questions
They are medicines that slow bone breakdown and can help reduce the risk of fractures and other bone complications caused by cancer.
Neither is automatically better for everyone. The choice depends on your cancer, kidney function, calcium levels, and other health factors.
No, they help protect the bones and manage complications but are usually used along with the main cancer treatment.
A dental check-up may be recommended because bisphosphonates and denosumab can rarely cause jawbone problems. Discuss your dental health with your cancer doctor before starting treatment.
Written and Verified by:
Dr. Gajendra Kumar Himanshu Exp: 10 Yr
Medical Officer
Book an Appointment
Related Blogs
IMRT and IGRT: How Modern Radiotherapy Spares Healthy Tissue
Learn the difference between IMRT and IGRT, how they work, their benefits, side effects, and role in precise cancer radiation treatment at Oncare Cancer Hospital.
Myelofibrosis: A Bone Marrow Disorder That Thickens With Scar Tissue
Learn about myelofibrosis, its causes, symptoms, diagnosis, bone marrow fibrosis, treatment options, and stem cell transplant at Oncare Cancer Hospital.
Ampullary Cancer: A Rare Tumour Near the Pancreas Explained
Learn about ampullary cancer, its symptoms, causes, diagnosis, Whipple surgery, treatment options, and recovery, with expert cancer care at Oncare Cancer Hospital.